315 related articles for article (PubMed ID: 34563202)
1. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors.
Liu HH; Yaron D; Piraino AS; Kapelusznik L
Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):69. PubMed ID: 34563202
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).
Kariyawasam RM; Julien DA; Jelinski DC; Larose SL; Rennert-May E; Conly JM; Dingle TC; Chen JZ; Tyrrell GJ; Ronksley PE; Barkema HW
Antimicrob Resist Infect Control; 2022 Mar; 11(1):45. PubMed ID: 35255988
[TBL] [Abstract][Full Text] [Related]
3. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
[TBL] [Abstract][Full Text] [Related]
4. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
[TBL] [Abstract][Full Text] [Related]
5. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
6. Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review.
Segala FV; Bavaro DF; Di Gennaro F; Salvati F; Marotta C; Saracino A; Murri R; Fantoni M
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834917
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
[TBL] [Abstract][Full Text] [Related]
9. Inadequate antibiotic therapy in solid organ transplant recipients is associated with a higher mortality rate.
Lupei MI; Mann HJ; Beilman GJ; Oancea C; Chipman JG
Surg Infect (Larchmt); 2010 Feb; 11(1):33-9. PubMed ID: 19785562
[TBL] [Abstract][Full Text] [Related]
10. A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19.
Puzniak L; Finelli L; Yu KC; Bauer KA; Moise P; De Anda C; Vankeepuram L; Sepassi A; Gupta V
BMC Infect Dis; 2021 Feb; 21(1):227. PubMed ID: 33639862
[TBL] [Abstract][Full Text] [Related]
11. Bacterial Coinfections in Coronavirus Disease 2019.
Westblade LF; Simon MS; Satlin MJ
Trends Microbiol; 2021 Oct; 29(10):930-941. PubMed ID: 33934980
[TBL] [Abstract][Full Text] [Related]
12. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.
Sieswerda E; de Boer MGJ; Bonten MMJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; van de Garde EMW; Verheij TJ; van der Eerden MM; Prins JM; Wiersinga WJ
Clin Microbiol Infect; 2021 Jan; 27(1):61-66. PubMed ID: 33010444
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
15. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.
Falcone M; Tiseo G; Giordano C; Leonildi A; Menichini M; Vecchione A; Pistello M; Guarracino F; Ghiadoni L; Forfori F; Barnini S; Menichetti F;
J Antimicrob Chemother; 2021 Mar; 76(4):1078-1084. PubMed ID: 33374002
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of antimicrobial resistance among hospital-associated pathogens.
Khan A; Miller WR; Arias CA
Expert Rev Anti Infect Ther; 2018 Apr; 16(4):269-287. PubMed ID: 29617188
[TBL] [Abstract][Full Text] [Related]
17. Bacterial infection, antibiotic use and COVID-19: Lessons from the intensive care unit.
Moolla MS; Reddy K; Fwemba I; Nyasulu PS; Taljaard JJ; Parker A; Louw EH; Nortje A; Parker MA; Lalla U; Koegelenberg CFN; Allwood BW
S Afr Med J; 2021 Apr; 111(6):575-581. PubMed ID: 34382570
[TBL] [Abstract][Full Text] [Related]
18. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
[TBL] [Abstract][Full Text] [Related]
19. Increased antimicrobial resistance during the COVID-19 pandemic.
Lai CC; Chen SY; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2021 Apr; 57(4):106324. PubMed ID: 33746045
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial prescription in severe COVID-19 and CAP: a matched case-control study.
Fierens J; De Bus L; Colpaert K; Boelens J; Gadeyne B; Decruyenaere J; Van Braeckel E; Depuydt P
Acta Clin Belg; 2022 Oct; 77(5):837-844. PubMed ID: 34709997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
